An artificial kidney, also known as an artificial dialysis device or a renal replacement therapy, is an externally worn medical device that is used as an alternative for failed kidneys. It works by removing waste products and excess water from the blood of patients with end-stage renal disease through a system of tubes and filters while also regulating levels of electrolytes like sodium, potassium, and calcium. The global artificial kidney market comprises devices used for both hemodialysis and peritoneal dialysis. Continuous improvements in dialysis technology have led to the development of compact at-home artificial kidneys that enable better quality of life for patients by greatly reducing treatment time and frequency.
The global artificial kidney market is estimated to be valued at US$ 7 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
These new devices reduce treatment times and frequency significantly by performing nocturnal hemodialysis and are small enough to be worn overnight at home. This leads to better quality of life outcomes for patients needing long-term dialysis support and an overall increase in accessibility and affordability of treatment. Another major driver is the rising prevalence of end-stage renal diseases globally. Conditions causing kidney damage like diabetes and hypertension are on the rise, leading to a growing patient base requiring either kidney transplantation or long-term dialysis. This increases the demand for innovative RRT systems like artificial kidneys.
Segment Analysis
The artificial kidney market can be segmented into hemodialysis products and peritoneal dialysis products. Hemodialysis products dominate the market with around 95% share. This is because hemodialysis is more effective at removing waste and extra water from the blood compared to peritoneal dialysis. It is also more suitable for patients who have issues with their peritoneal membrane or have ongoing infections.
PEST Analysis
Political: Governments across major countries are focusing on increasing healthcare funding and developing kidney disease management programs. For example, the U.S. government expanded Medicaid coverage for chronic kidney disease in 2021.
Economic: Rising incidence of kidney failure along with growing elderly population is driving demand. However, high cost of treatment may act as a restrain.
Social: Growing awareness about organ donation and kidney transplantation has increased demand for dialysis products. Sedentary lifestyles and junk food consumption have increased risk of kidney diseases.
Technological: Companies are developing innovative home hemodialysis systems and portable artificial kidneys to improve quality of life of patients. Wearable artificial kidney is under development stage.
Key Takeaways
The Global Artificial Kidney Market Size is expected to witness high growth over the forecast period supported by increasing renal disease burden.
Regional analysis: North America dominates the market currently due to high healthcare spending and presence of key players. However, Asia Pacific is expected to grow at the fastest pace due to rising Incidence of chronic kidney disease in countries like India and China.
Key players: Key players operating in the artificial kidney market are DanDry, Bry-Air, Drymate, DehuTech AB, Aprilaire, Therma-Stor LLC, Santa Fe Products, Surna Inc., Desert Aire Corp.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it